当前位置: 首页 > 期刊 > 《中国医学创新》 > 2012年第12期 > 正文
编号:12280896
舍曲林联合丁螺环酮与舍曲林单药治疗抑郁症的对照研究(3)
http://www.100md.com 2012年4月25日 晏桂萍 朱志雾 丁寒春
第1页

    参见附件。

     [4] 李轶群.丁螺环酮与盐酸马普替林治疗抑郁症对照研究[J].实用临床医药,2008,9(12):43-45.

    [5] 袁纯玲.丁螺环酮与盐酸舍曲林联合治疗抑郁症临床观察[J].中国现代药物应用,2009,3(5):87-88.

    [6] Appelberg B G, Syvalahti E K, Koskinen T E, et al. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study[J]. J Clin Psychiatry,2001,62(6):448-452.

    [7] Onder E, Tural U. Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone[J]. J Affect Disorder,2003,76(1-3):223-227.

    [8] Reimherr F W, Chouinard G, Cohn C K, et al. Antidepressant efficacy of sertraline: a double-blind, placebo-and amitriptyline-controlled, multicenter comparison study in outpatients with major depression[J]. J Clin Psychiatry,1990,51(B):18-27.

    [9] Montejo A L, Llorca G, Lzquierdo J A, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients[J]. J Clin Psychiatry,2001,62(3):10-21.

    (收稿日期:2012-02-29) (本文编辑:王宇)

您现在查看是摘要介绍页,详见PDF附件(3714kb)